SCHEMBL29753138

SCHEMBL29753138

C#CC1CC12CCCNC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31460294 0.80 CYP1A2 (0.31)
SCHEMBL29753717 0.74
SCHEMBL9566400 0.70
SCHEMBL16984316 0.70
SCHEMBL23466226 0.70
Hydrochloric Acid SCHEMBL9566486 0.68
SCHEMBL24819506 0.67
Hydrochloric Acid SCHEMBL30037141 0.65
SCHEMBL16984975 0.64 TSHR (0.30)
SCHEMBL11759566 0.64 HTR2A (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12569564-B2 Spirocyclic MDM2 modulator and uses thereof NEWAVE PHARMACEUTICAL INC. (US) 2026-03-10 US disclosed
US-20250073340-A1 SPIROCYCLIC MDM2 MODULATOR AND USES THEREOF NEWAVE PHARMACEUTICAL INC. 2025-03-06 US disclosed
WO-2022159644-A1 SPIROCYCLIC MDM2 MODULATOR AND USES THEREOF NEWAVE PHARMACEUTICAL INC. (US) 2022-07-28 WO disclosed